Human CD40LG/CD154/CD40L ORF/cDNA clone-Adenovirus plasmid (BC071754)
Cat. No.: pGMAP000295
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human CD40LG/CD154/CD40L adenoviral expression plasmid for CD40LG adenovirus packaging, CD40LG adenovirus.
Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.
Go to
CD40LG/CD154/CD40LG/CD154 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMAP000295 |
| Gene Name | CD40LG |
| Accession Number | BC071754 |
| Gene ID | 959 |
| Species | Human |
| Product Type | Adenovirus plasmid (overexpression) |
| Insert Length | 786 bp |
| Gene Alias | CD154,CD40L,gp39,hCD40L,IGM,T-BAM,TRAP |
| Fluorescent Reporter | GFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGATCGAAACATACAACCAAACTTCTCCCCGATCTGCGGCCACTGGACTGCCCATCAGCATGAAAATTTTTATGTATTTACTTACTGTTTTTCTTATCACCCAGATGATTGGGTCAGCACTTTTTGCTGTGTATCTTCATAGAAGGTTGGACAAGATAGAAGATGAAAGGAATCTTCATGAAGATTTTGTATTCATGAAAACGATACAGAGATGCAACACAGGAGAAAGATCCTTATCCTTACTGAACTGTGAGGAGATTAAAAGCCAGTTTGAAGGCTTTGTGAAGGATATAATGTTAAACAAAGAGGAGACGAAGAAAGAAAACAGCTTTGAAATGCAAAAAGGTGATCAGAATCCTCAAATTGCGGCACATGTCATAAGTGAGGCCAGCAGTAAAACAACATCTGTGTTACAGTGGGCTGAAAAAGGATACTACACCATGAGCAACAACTTGGTAACCCTGGAAAATGGGAAACAGCTGACCGTTAAAAGACAAGGACTCTATTATATCTATGCCCAAGTCACCTTCTGTTCCAATCGGGAAGCTTCGAGTCAAGCTCCATTTATAGCCAGCCTCTGCCTAAAGTCCCCCGGTAGATTCGAGAGAATCTTACTCAGAGCTGCAAATACCCACAGTTCCGCCAAACCTTGCGGGCAACAATCCATTCACTTGGGAGGAGTATTTGAATTGCAACCAGGTGCTTCGGTGTTTGTCAATGTGACTGATCCAAGCCAAGTGAGCCATGGCACTGGCTTCACGTCCTTTGGCTTACTCAAACTCTGA |
| ORF Protein Sequence | MIETYNQTSPRSAATGLPISMKIFMYLLTVFLITQMIGSALFAVYLHRRLDKIEDERNLHEDFVFMKTIQRCNTGERSLSLLNCEEIKSQFEGFVKDIMLNKEETKKENSFEMQKGDQNPQIAAHVISEASSKTTSVLQWAEKGYYTMSNNLVTLENGKQLTVKRQGLYYIYAQVTFCSNREASSQAPFIASLCLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVFVNVTDPSQVSHGTGFTSFGLLKL |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Target information
| Target ID | GM-T14755 |
| Target Name | CD40LG/CD154 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
959 |
| Gene ID |
100054624 (Equus caballus), 21947 (Mus musculus), 403468 (Canis lupus familiaris), 493850 (Felis catus) 574160 (Macaca mulatta), 84349 (Rattus norvegicus), 959 (Homo sapiens) |
| Gene Symbols & Synonyms | CD40LG,Cd40lg,cd154,TNLG8B,IGM,IMD3,Ly62,TRAP,gp39,CD154,Cd40l,HIGM1,Ly-62,T-BAM,CD40-L,Tnfsf5,Tnlg8b,TNFSF5,CD40L,hCD40L |
| Target Alternative Names | CD154,CD40 ligand,CD40-L,CD40L,CD40LG,Cd40l,Cd40lg,HIGM1,IGM,IMD3,Ly-62,Ly62,T-BAM,T-cell antigen Gp39,TNF-related activation protein (TRAP),TNFSF5,TNLG8B,TRAP,Tnfsf5,Tnlg8b,Tumor necrosis factor ligand superfamily member 5,cd154,gp39,hCD40L |
| Uniprot Accession |
O97605,O97626,P27548,P29965,P63304,Q9Z2V2
Additional SwissProt Accessions: P27548,O97626,O97605,P63304,Q9Z2V2,P29965 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target, Immuno-oncology Target, INN Index, Cytokine Target |
| Disease | |
| Disease from KEGG | Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Cell adhesion molecules, T cell receptor signaling pathway, Intestinal immune network for IgA production, Malaria, Toxoplasmosis, Asthma, Autoimmune thyroid disease, Allograft rejection, Viral myocarditis, Lipid and atherosclerosis |
| Gene Ensembl | ENSECAG00000011392, ENSMUSG00000031132, ENSCAFG00845029290, ENSMMUG00000013773, ENSG00000102245 |
| Target Classification | Checkpoint-Immuno Oncology |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


